Addus HomeCareADUS +1.75%92 EBITDA Margin % is 10.62% as of Mar. 2026, which is 30% above its 10-year median of 8.15. GuruFocus rates ADUS with a GF Score™ of 92/100 and a GF Value™ of $123.39 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 668 Healthcare Providers & Services companies, Addus HomeCare ranks better than 53.14% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Addus HomeCare's EBITDA for the
three
months ended in Mar. 2026 was $39 Mil. Addus HomeCare's Revenue for the
three
months ended in Mar. 2026 was $364 Mil. Therefore, Addus HomeCare's EBITDA margin for the quarter that ended in Mar. 2026 was 10.62%.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Addus HomeCare EBITDA Margin % Related Terms
Addus HomeCare EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Addus HomeCare's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ADUS vs SGRY, SNDA, MD: EBITDA Margin % Comparison
For the Medical Care Facilities subindustry, Addus HomeCare's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Addus HomeCare EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Addus HomeCare's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Addus HomeCare's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Addus HomeCare (ADUS) has a EBITDA Margin % of 10.62% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Addus HomeCare and its competitors. This is 30% above median its historical median of 8.15. Over the past decade, Addus HomeCare's EBITDA Margin % has ranged from 6.27 to 11.12. According to the industry distribution chart, Addus HomeCare ranks #313 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 46.9%.
Is Addus HomeCare's EBITDA Margin % too high?
Addus HomeCare's current EBITDA Margin % of 10.62% is 30% above median its 10-year median of 8.15. Over the past 10 years, this metric has ranged from a low of 6.27 to a high of 11.12. The Healthcare Providers & Services industry median EBITDA Margin % is 10.21. Addus HomeCare's value of 10.62% is 4% above this industry median. Based on the distribution chart, Addus HomeCare ranks #313 out of 668 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Addus HomeCare has a GF Score™ of 92/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Addus HomeCare's EBITDA Margin % compare to SGRY and SNDA?
According to the Healthcare Providers & Services industry distribution chart, Addus HomeCare ranks #313 out of 668 companies for EBITDA Margin %. This puts Addus HomeCare in the upper half of its industry. The industry median EBITDA Margin % is 10.21. Addus HomeCare's value of 10.62% is 4% above this benchmark. Historically, Addus HomeCare's own EBITDA Margin % has ranged from 6.27 to 11.12 over the past decade. While the company's 10-year median is 8.15 vs. the industry median of 10.21, Addus HomeCare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.21, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Addus HomeCare's current EBITDA Margin % of 10.62% is 4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Addus HomeCare and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Addus HomeCare's current EBITDA Margin % is 10.62%, which is 30% above median its own 10-year median of 8.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Addus HomeCare stock overvalued right now?
Based on GuruFocus' analysis, Addus HomeCare (ADUS) is currently considered Modestly Undervalued. The stock's GF Value™ is $123.39, compared to a current price of $97.78 — trading 20.8% below its estimated fair value. The current EBITDA Margin % is 10.62%, which is 30% above median its 10-year median of 8.15 and 4% above the Healthcare Providers & Services industry median of 10.21. Addus HomeCare's overall GF Score™ is 92/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Addus HomeCare (ADUS), the current EBITDA Margin % is 10.62% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Addus HomeCare (ADUS) Overvalued in 2026?
Based on GuruFocus' analysis, Addus HomeCare stock appears to be undervalued.
The current stock price of $97.78 is trading 20.8% below its estimated GF Value™ of $123.39.
GuruFocus considers Addus HomeCare to be Modestly Undervalued.
Key valuation signals for ADUS:
EBITDA Margin %: 10.62% (30% above median its 10-year median of 8.15)
GF Value™: $123.39 vs. price of $97.78 (20.8% below fair value)
Industry Position: 4% above the Healthcare Providers & Services median (#313 of 668)
No single metric tells the full story. See the ADUS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Addus HomeCare Corp is engaged in the provision of in-home care services. The Company has three reportable segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living, mainly to the elderly, chronically ill, and disabled individuals. The Hospice segment provides physical, emotional, and spiritual care for terminally ill patients and their families. The Home Health segment provides medical services to individuals requiring care during illness or recovery. It generates the majority of its revenue from the Personal Care segment.
92GF Score
Get the complete analysis for ADUS
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ADUS has been successfully added to your 
